Global Inhalation CDMO Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Inhalation CDMO (Contract Development and Manufacturing Organization) refers to specialized companies that provide end-to-end services in the development and manufacturing of inhalable drugs and therapies. These organizations work with pharmaceutical companies to design, develop, test, and produce inhalation products, such as metered-dose inhalers, dry powder inhalers, and nebulizers. The services offered by inhalation CDMOs typically include formulation development, analytical testing, device engineering, clinical trial manufacturing, and large-scale commercial production. By leveraging their expertise, CDMOs help bring inhalation therapies to market more efficiently and with greater compliance to regulatory standards.
The global Inhalation CDMO market size is projected to grow from US$ 3085 million in 2024 to US$ 5966 million in 2030; it is expected to grow at a CAGR of 11.6% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Inhalation CDMO Industry Forecast” looks at past sales and reviews total world Inhalation CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Inhalation CDMO sales for 2023 through 2029. With Inhalation CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalation CDMO industry.
This Insight Report provides a comprehensive analysis of the global Inhalation CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Inhalation CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhalation CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalation CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalation CDMO.
Inhalation Contract Development and Manufacturing Organizations (CDMOs) are specialized service providers that assist pharmaceutical companies in the development and production of inhalation products, such as inhalers and nebulizers. The market for inhalation CDMOs is growing steadily, driven by the increasing prevalence of respiratory diseases like asthma and COPD, and the rising demand for complex inhalation therapies. The North America and Europe are the major sales regions, although significant growth is also expected in Asia-Pacific. Market opportunities lie in the development of novel drug delivery systems, biologics, and personalized medicine, while challenges include regulatory complexities and the high cost of development. Future product trends point towards the integration of digital health technologies and sustainable packaging solutions in inhalation products.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Inhalation CDMO (Contract Development and Manufacturing Organization) refers to specialized companies that provide end-to-end services in the development and manufacturing of inhalable drugs and therapies. These organizations work with pharmaceutical companies to design, develop, test, and produce inhalation products, such as metered-dose inhalers, dry powder inhalers, and nebulizers. The services offered by inhalation CDMOs typically include formulation development, analytical testing, device engineering, clinical trial manufacturing, and large-scale commercial production. By leveraging their expertise, CDMOs help bring inhalation therapies to market more efficiently and with greater compliance to regulatory standards.
The global Inhalation CDMO market size is projected to grow from US$ 3085 million in 2024 to US$ 5966 million in 2030; it is expected to grow at a CAGR of 11.6% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Inhalation CDMO Industry Forecast” looks at past sales and reviews total world Inhalation CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Inhalation CDMO sales for 2023 through 2029. With Inhalation CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalation CDMO industry.
This Insight Report provides a comprehensive analysis of the global Inhalation CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Inhalation CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhalation CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalation CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalation CDMO.
Inhalation Contract Development and Manufacturing Organizations (CDMOs) are specialized service providers that assist pharmaceutical companies in the development and production of inhalation products, such as inhalers and nebulizers. The market for inhalation CDMOs is growing steadily, driven by the increasing prevalence of respiratory diseases like asthma and COPD, and the rising demand for complex inhalation therapies. The North America and Europe are the major sales regions, although significant growth is also expected in Asia-Pacific. Market opportunities lie in the development of novel drug delivery systems, biologics, and personalized medicine, while challenges include regulatory complexities and the high cost of development. Future product trends point towards the integration of digital health technologies and sustainable packaging solutions in inhalation products.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Metered Dose Inhalers (MDIs)
- Dry Powder Inhalers (DPIs)
- Soft Mist Inhalers (SMIs)
- Others
- Commercial
- Academic Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Metered Dose Inhalers (MDIs)
- Dry Powder Inhalers (DPIs)
- Soft Mist Inhalers (SMIs)
- Others
- Commercial
- Academic Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Vectura
- Iconovo
- CritiTech
- Hovione
- Recipharm
- Aptar Pharma
- Kindeva
- Sanner
- Particle Sciences
- Experic
- Enteris Biopharma
- Catalent
- HCmed
- Ritedose
- Bespak
- Proveris
- Bend Bioscience
- Renejix
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhalation CDMO Market Size 2019-2030
2.1.2 Inhalation CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Inhalation CDMO by Country/Region, 2019, 2023 & 2030
2.2 Inhalation CDMO Segment by Type
2.2.1 Metered Dose Inhalers (MDIs)
2.2.2 Dry Powder Inhalers (DPIs)
2.2.3 Soft Mist Inhalers (SMIs)
2.2.4 Others
2.3 Inhalation CDMO Market Size by Type
2.3.1 Inhalation CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Inhalation CDMO Market Size Market Share by Type (2019-2024)
2.4 Inhalation CDMO Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.4.3 Others
2.5 Inhalation CDMO Market Size by Application
2.5.1 Inhalation CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Inhalation CDMO Market Size Market Share by Application (2019-2024)
3 INHALATION CDMO MARKET SIZE BY PLAYER
3.1 Inhalation CDMO Market Size Market Share by Player
3.1.1 Global Inhalation CDMO Revenue by Player (2019-2024)
3.1.2 Global Inhalation CDMO Revenue Market Share by Player (2019-2024)
3.2 Global Inhalation CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INHALATION CDMO BY REGION
4.1 Inhalation CDMO Market Size by Region (2019-2024)
4.2 Global Inhalation CDMO Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhalation CDMO Market Size Growth (2019-2024)
4.4 APAC Inhalation CDMO Market Size Growth (2019-2024)
4.5 Europe Inhalation CDMO Market Size Growth (2019-2024)
4.6 Middle East & Africa Inhalation CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Inhalation CDMO Market Size by Country (2019-2024)
5.2 Americas Inhalation CDMO Market Size by Type (2019-2024)
5.3 Americas Inhalation CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalation CDMO Market Size by Region (2019-2024)
6.2 APAC Inhalation CDMO Market Size by Type (2019-2024)
6.3 APAC Inhalation CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Inhalation CDMO Market Size by Country (2019-2024)
7.2 Europe Inhalation CDMO Market Size by Type (2019-2024)
7.3 Europe Inhalation CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhalation CDMO by Region (2019-2024)
8.2 Middle East & Africa Inhalation CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Inhalation CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INHALATION CDMO MARKET FORECAST
10.1 Global Inhalation CDMO Forecast by Region (2025-2030)
10.1.1 Global Inhalation CDMO Forecast by Region (2025-2030)
10.1.2 Americas Inhalation CDMO Forecast
10.1.3 APAC Inhalation CDMO Forecast
10.1.4 Europe Inhalation CDMO Forecast
10.1.5 Middle East & Africa Inhalation CDMO Forecast
10.2 Americas Inhalation CDMO Forecast by Country (2025-2030)
10.2.1 United States Market Inhalation CDMO Forecast
10.2.2 Canada Market Inhalation CDMO Forecast
10.2.3 Mexico Market Inhalation CDMO Forecast
10.2.4 Brazil Market Inhalation CDMO Forecast
10.3 APAC Inhalation CDMO Forecast by Region (2025-2030)
10.3.1 China Inhalation CDMO Market Forecast
10.3.2 Japan Market Inhalation CDMO Forecast
10.3.3 Korea Market Inhalation CDMO Forecast
10.3.4 Southeast Asia Market Inhalation CDMO Forecast
10.3.5 India Market Inhalation CDMO Forecast
10.3.6 Australia Market Inhalation CDMO Forecast
10.4 Europe Inhalation CDMO Forecast by Country (2025-2030)
10.4.1 Germany Market Inhalation CDMO Forecast
10.4.2 France Market Inhalation CDMO Forecast
10.4.3 UK Market Inhalation CDMO Forecast
10.4.4 Italy Market Inhalation CDMO Forecast
10.4.5 Russia Market Inhalation CDMO Forecast
10.5 Middle East & Africa Inhalation CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Market Inhalation CDMO Forecast
10.5.2 South Africa Market Inhalation CDMO Forecast
10.5.3 Israel Market Inhalation CDMO Forecast
10.5.4 Turkey Market Inhalation CDMO Forecast
10.6 Global Inhalation CDMO Forecast by Type (2025-2030)
10.7 Global Inhalation CDMO Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Inhalation CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Inhalation CDMO Product Offered
11.1.3 Lonza Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Vectura
11.2.1 Vectura Company Information
11.2.2 Vectura Inhalation CDMO Product Offered
11.2.3 Vectura Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Vectura Main Business Overview
11.2.5 Vectura Latest Developments
11.3 Iconovo
11.3.1 Iconovo Company Information
11.3.2 Iconovo Inhalation CDMO Product Offered
11.3.3 Iconovo Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Iconovo Main Business Overview
11.3.5 Iconovo Latest Developments
11.4 CritiTech
11.4.1 CritiTech Company Information
11.4.2 CritiTech Inhalation CDMO Product Offered
11.4.3 CritiTech Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CritiTech Main Business Overview
11.4.5 CritiTech Latest Developments
11.5 Hovione
11.5.1 Hovione Company Information
11.5.2 Hovione Inhalation CDMO Product Offered
11.5.3 Hovione Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hovione Main Business Overview
11.5.5 Hovione Latest Developments
11.6 Recipharm
11.6.1 Recipharm Company Information
11.6.2 Recipharm Inhalation CDMO Product Offered
11.6.3 Recipharm Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Recipharm Main Business Overview
11.6.5 Recipharm Latest Developments
11.7 Aptar Pharma
11.7.1 Aptar Pharma Company Information
11.7.2 Aptar Pharma Inhalation CDMO Product Offered
11.7.3 Aptar Pharma Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aptar Pharma Main Business Overview
11.7.5 Aptar Pharma Latest Developments
11.8 Kindeva
11.8.1 Kindeva Company Information
11.8.2 Kindeva Inhalation CDMO Product Offered
11.8.3 Kindeva Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kindeva Main Business Overview
11.8.5 Kindeva Latest Developments
11.9 Sanner
11.9.1 Sanner Company Information
11.9.2 Sanner Inhalation CDMO Product Offered
11.9.3 Sanner Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanner Main Business Overview
11.9.5 Sanner Latest Developments
11.10 Particle Sciences
11.10.1 Particle Sciences Company Information
11.10.2 Particle Sciences Inhalation CDMO Product Offered
11.10.3 Particle Sciences Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Particle Sciences Main Business Overview
11.10.5 Particle Sciences Latest Developments
11.11 Experic
11.11.1 Experic Company Information
11.11.2 Experic Inhalation CDMO Product Offered
11.11.3 Experic Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Experic Main Business Overview
11.11.5 Experic Latest Developments
11.12 Enteris Biopharma
11.12.1 Enteris Biopharma Company Information
11.12.2 Enteris Biopharma Inhalation CDMO Product Offered
11.12.3 Enteris Biopharma Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Enteris Biopharma Main Business Overview
11.12.5 Enteris Biopharma Latest Developments
11.13 Catalent
11.13.1 Catalent Company Information
11.13.2 Catalent Inhalation CDMO Product Offered
11.13.3 Catalent Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Catalent Main Business Overview
11.13.5 Catalent Latest Developments
11.14 HCmed
11.14.1 HCmed Company Information
11.14.2 HCmed Inhalation CDMO Product Offered
11.14.3 HCmed Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 HCmed Main Business Overview
11.14.5 HCmed Latest Developments
11.15 Ritedose
11.15.1 Ritedose Company Information
11.15.2 Ritedose Inhalation CDMO Product Offered
11.15.3 Ritedose Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Ritedose Main Business Overview
11.15.5 Ritedose Latest Developments
11.16 Bespak
11.16.1 Bespak Company Information
11.16.2 Bespak Inhalation CDMO Product Offered
11.16.3 Bespak Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Bespak Main Business Overview
11.16.5 Bespak Latest Developments
11.17 Proveris
11.17.1 Proveris Company Information
11.17.2 Proveris Inhalation CDMO Product Offered
11.17.3 Proveris Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Proveris Main Business Overview
11.17.5 Proveris Latest Developments
11.18 Bend Bioscience
11.18.1 Bend Bioscience Company Information
11.18.2 Bend Bioscience Inhalation CDMO Product Offered
11.18.3 Bend Bioscience Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Bend Bioscience Main Business Overview
11.18.5 Bend Bioscience Latest Developments
11.19 Renejix
11.19.1 Renejix Company Information
11.19.2 Renejix Inhalation CDMO Product Offered
11.19.3 Renejix Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Renejix Main Business Overview
11.19.5 Renejix Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1. Inhalation CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Inhalation CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Metered Dose Inhalers (MDIs)
Table 4. Major Players of Dry Powder Inhalers (DPIs)
Table 5. Major Players of Soft Mist Inhalers (SMIs)
Table 6. Major Players of Others
Table 7. Inhalation CDMO Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 9. Global Inhalation CDMO Market Size Market Share byType (2019-2024)
Table 10. Inhalation CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Inhalation CDMO Market Size Market Share by Application (2019-2024)
Table 13. Global Inhalation CDMO Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Inhalation CDMO Revenue Market Share by Player (2019-2024)
Table 15. Inhalation CDMO Key Players Head office and Products Offered
Table 16. Inhalation CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Inhalation CDMO Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Inhalation CDMO Market Size Market Share by Region (2019-2024)
Table 21. Global Inhalation CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Inhalation CDMO Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Inhalation CDMO Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Inhalation CDMO Market Size Market Share by Country (2019-2024)
Table 25. Americas Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 26. Americas Inhalation CDMO Market Size Market Share byType (2019-2024)
Table 27. Americas Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Inhalation CDMO Market Size Market Share by Application (2019-2024)
Table 29. APAC Inhalation CDMO Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Inhalation CDMO Market Size Market Share by Region (2019-2024)
Table 31. APAC Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 32. APAC Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Inhalation CDMO Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Inhalation CDMO Market Size Market Share by Country (2019-2024)
Table 35. Europe Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 36. Europe Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Inhalation CDMO Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 39. Middle East & Africa Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Inhalation CDMO
Table 41. Key Market Challenges & Risks of Inhalation CDMO
Table 42. Key IndustryTrends of Inhalation CDMO
Table 43. Global Inhalation CDMO Market SizeForecast by Region (2025-2030) & ($ millions)
Table 44. Global Inhalation CDMO Market Size Market ShareForecast by Region (2025-2030)
Table 45. Global Inhalation CDMO Market SizeForecast byType (2025-2030) & ($ millions)
Table 46. Global Inhalation CDMO Market SizeForecast by Application (2025-2030) & ($ millions)
Table 47. Lonza Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 48. Lonza Inhalation CDMO Product Offered
Table 49. Lonza Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Vectura Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 53. Vectura Inhalation CDMO Product Offered
Table 54. Vectura Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Vectura Main Business
Table 56. Vectura Latest Developments
Table 57. Iconovo Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 58. Iconovo Inhalation CDMO Product Offered
Table 59. Iconovo Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Iconovo Main Business
Table 61. Iconovo Latest Developments
Table 62. CritiTech Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 63. CritiTech Inhalation CDMO Product Offered
Table 64. CritiTech Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. CritiTech Main Business
Table 66. CritiTech Latest Developments
Table 67. Hovione Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 68. Hovione Inhalation CDMO Product Offered
Table 69. Hovione Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Hovione Main Business
Table 71. Hovione Latest Developments
Table 72. Recipharm Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 73. Recipharm Inhalation CDMO Product Offered
Table 74. Recipharm Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Recipharm Main Business
Table 76. Recipharm Latest Developments
Table 77. Aptar Pharma Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 78. Aptar Pharma Inhalation CDMO Product Offered
Table 79. Aptar Pharma Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Aptar Pharma Main Business
Table 81. Aptar Pharma Latest Developments
Table 82. Kindeva Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 83. Kindeva Inhalation CDMO Product Offered
Table 84. Kindeva Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Kindeva Main Business
Table 86. Kindeva Latest Developments
Table 87. Sanner Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 88. Sanner Inhalation CDMO Product Offered
Table 89. Sanner Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Sanner Main Business
Table 91. Sanner Latest Developments
Table 92. Particle Sciences Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 93. Particle Sciences Inhalation CDMO Product Offered
Table 94. Particle Sciences Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Particle Sciences Main Business
Table 96. Particle Sciences Latest Developments
Table 97. Experic Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 98. Experic Inhalation CDMO Product Offered
Table 99. Experic Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Experic Main Business
Table 101. Experic Latest Developments
Table 102. Enteris Biopharma Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 103. Enteris Biopharma Inhalation CDMO Product Offered
Table 104. Enteris Biopharma Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Enteris Biopharma Main Business
Table 106. Enteris Biopharma Latest Developments
Table 107. Catalent Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 108. Catalent Inhalation CDMO Product Offered
Table 109. Catalent Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Catalent Main Business
Table 111. Catalent Latest Developments
Table 112. HCmed Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 113. HCmed Inhalation CDMO Product Offered
Table 114. HCmed Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. HCmed Main Business
Table 116. HCmed Latest Developments
Table 117. Ritedose Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 118. Ritedose Inhalation CDMO Product Offered
Table 119. Ritedose Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Ritedose Main Business
Table 121. Ritedose Latest Developments
Table 122. Bespak Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 123. Bespak Inhalation CDMO Product Offered
Table 124. Bespak Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Bespak Main Business
Table 126. Bespak Latest Developments
Table 127. Proveris Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 128. Proveris Inhalation CDMO Product Offered
Table 129. Proveris Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Proveris Main Business
Table 131. Proveris Latest Developments
Table 132. Bend Bioscience Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 133. Bend Bioscience Inhalation CDMO Product Offered
Table 134. Bend Bioscience Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. Bend Bioscience Main Business
Table 136. Bend Bioscience Latest Developments
Table 137. Renejix Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 138. Renejix Inhalation CDMO Product Offered
Table 139. Renejix Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. Renejix Main Business
Table 141. Renejix Latest Developments
LIST OFFIGURES
.
Figure 1. Inhalation CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Inhalation CDMO Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Inhalation CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Inhalation CDMO Sales Market Share by Country/Region (2023)
Figure 8. Inhalation CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Inhalation CDMO Market Size Market Share byType in 2023
Figure 10. Inhalation CDMO in Commercial
Figure 11. Global Inhalation CDMO Market: Commercial (2019-2024) & ($ millions)
Figure 12. Inhalation CDMO in Academic Research
Figure 13. Global Inhalation CDMO Market: Academic Research (2019-2024) & ($ millions)
Figure 14. Inhalation CDMO in Others
Figure 15. Global Inhalation CDMO Market: Others (2019-2024) & ($ millions)
Figure 16. Global Inhalation CDMO Market Size Market Share by Application in 2023
Figure 17. Global Inhalation CDMO Revenue Market Share by Player in 2023
Figure 18. Global Inhalation CDMO Market Size Market Share by Region (2019-2024)
Figure 19. Americas Inhalation CDMO Market Size 2019-2024 ($ millions)
Figure 20. APAC Inhalation CDMO Market Size 2019-2024 ($ millions)
Figure 21. Europe Inhalation CDMO Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Inhalation CDMO Market Size 2019-2024 ($ millions)
Figure 23. Americas Inhalation CDMO Value Market Share by Country in 2023
Figure 24. United States Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Inhalation CDMO Market Size Market Share by Region in 2023
Figure 29. APAC Inhalation CDMO Market Size Market Share byType (2019-2024)
Figure 30. APAC Inhalation CDMO Market Size Market Share by Application (2019-2024)
Figure 31. China Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 35. India Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Inhalation CDMO Market Size Market Share by Country in 2023
Figure 38. Europe Inhalation CDMO Market Size Market Share byType (2019-2024)
Figure 39. Europe Inhalation CDMO Market Size Market Share by Application (2019-2024)
Figure 40. Germany Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 41.France Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Inhalation CDMO Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Inhalation CDMO Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa Inhalation CDMO Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 51.Turkey Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 54. APAC Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 55. Europe Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 57. United States Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 58. Canada Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 59. Mexico Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 60. Brazil Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 61. China Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 62. Japan Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 63. Korea Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 65. India Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 66. Australia Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 67. Germany Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 68.France Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 69. UK Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 70. Italy Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 71. Russia Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 72. Egypt Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 73. South Africa Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 74. Israel Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 75.Turkey Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 77. Global Inhalation CDMO Market Size Market ShareForecast byType (2025-2030)
Figure 78. Global Inhalation CDMO Market Size Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhalation CDMO Market Size 2019-2030
2.1.2 Inhalation CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Inhalation CDMO by Country/Region, 2019, 2023 & 2030
2.2 Inhalation CDMO Segment by Type
2.2.1 Metered Dose Inhalers (MDIs)
2.2.2 Dry Powder Inhalers (DPIs)
2.2.3 Soft Mist Inhalers (SMIs)
2.2.4 Others
2.3 Inhalation CDMO Market Size by Type
2.3.1 Inhalation CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Inhalation CDMO Market Size Market Share by Type (2019-2024)
2.4 Inhalation CDMO Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.4.3 Others
2.5 Inhalation CDMO Market Size by Application
2.5.1 Inhalation CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Inhalation CDMO Market Size Market Share by Application (2019-2024)
3 INHALATION CDMO MARKET SIZE BY PLAYER
3.1 Inhalation CDMO Market Size Market Share by Player
3.1.1 Global Inhalation CDMO Revenue by Player (2019-2024)
3.1.2 Global Inhalation CDMO Revenue Market Share by Player (2019-2024)
3.2 Global Inhalation CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INHALATION CDMO BY REGION
4.1 Inhalation CDMO Market Size by Region (2019-2024)
4.2 Global Inhalation CDMO Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhalation CDMO Market Size Growth (2019-2024)
4.4 APAC Inhalation CDMO Market Size Growth (2019-2024)
4.5 Europe Inhalation CDMO Market Size Growth (2019-2024)
4.6 Middle East & Africa Inhalation CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Inhalation CDMO Market Size by Country (2019-2024)
5.2 Americas Inhalation CDMO Market Size by Type (2019-2024)
5.3 Americas Inhalation CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalation CDMO Market Size by Region (2019-2024)
6.2 APAC Inhalation CDMO Market Size by Type (2019-2024)
6.3 APAC Inhalation CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Inhalation CDMO Market Size by Country (2019-2024)
7.2 Europe Inhalation CDMO Market Size by Type (2019-2024)
7.3 Europe Inhalation CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhalation CDMO by Region (2019-2024)
8.2 Middle East & Africa Inhalation CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Inhalation CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INHALATION CDMO MARKET FORECAST
10.1 Global Inhalation CDMO Forecast by Region (2025-2030)
10.1.1 Global Inhalation CDMO Forecast by Region (2025-2030)
10.1.2 Americas Inhalation CDMO Forecast
10.1.3 APAC Inhalation CDMO Forecast
10.1.4 Europe Inhalation CDMO Forecast
10.1.5 Middle East & Africa Inhalation CDMO Forecast
10.2 Americas Inhalation CDMO Forecast by Country (2025-2030)
10.2.1 United States Market Inhalation CDMO Forecast
10.2.2 Canada Market Inhalation CDMO Forecast
10.2.3 Mexico Market Inhalation CDMO Forecast
10.2.4 Brazil Market Inhalation CDMO Forecast
10.3 APAC Inhalation CDMO Forecast by Region (2025-2030)
10.3.1 China Inhalation CDMO Market Forecast
10.3.2 Japan Market Inhalation CDMO Forecast
10.3.3 Korea Market Inhalation CDMO Forecast
10.3.4 Southeast Asia Market Inhalation CDMO Forecast
10.3.5 India Market Inhalation CDMO Forecast
10.3.6 Australia Market Inhalation CDMO Forecast
10.4 Europe Inhalation CDMO Forecast by Country (2025-2030)
10.4.1 Germany Market Inhalation CDMO Forecast
10.4.2 France Market Inhalation CDMO Forecast
10.4.3 UK Market Inhalation CDMO Forecast
10.4.4 Italy Market Inhalation CDMO Forecast
10.4.5 Russia Market Inhalation CDMO Forecast
10.5 Middle East & Africa Inhalation CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Market Inhalation CDMO Forecast
10.5.2 South Africa Market Inhalation CDMO Forecast
10.5.3 Israel Market Inhalation CDMO Forecast
10.5.4 Turkey Market Inhalation CDMO Forecast
10.6 Global Inhalation CDMO Forecast by Type (2025-2030)
10.7 Global Inhalation CDMO Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Inhalation CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Inhalation CDMO Product Offered
11.1.3 Lonza Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Vectura
11.2.1 Vectura Company Information
11.2.2 Vectura Inhalation CDMO Product Offered
11.2.3 Vectura Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Vectura Main Business Overview
11.2.5 Vectura Latest Developments
11.3 Iconovo
11.3.1 Iconovo Company Information
11.3.2 Iconovo Inhalation CDMO Product Offered
11.3.3 Iconovo Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Iconovo Main Business Overview
11.3.5 Iconovo Latest Developments
11.4 CritiTech
11.4.1 CritiTech Company Information
11.4.2 CritiTech Inhalation CDMO Product Offered
11.4.3 CritiTech Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CritiTech Main Business Overview
11.4.5 CritiTech Latest Developments
11.5 Hovione
11.5.1 Hovione Company Information
11.5.2 Hovione Inhalation CDMO Product Offered
11.5.3 Hovione Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hovione Main Business Overview
11.5.5 Hovione Latest Developments
11.6 Recipharm
11.6.1 Recipharm Company Information
11.6.2 Recipharm Inhalation CDMO Product Offered
11.6.3 Recipharm Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Recipharm Main Business Overview
11.6.5 Recipharm Latest Developments
11.7 Aptar Pharma
11.7.1 Aptar Pharma Company Information
11.7.2 Aptar Pharma Inhalation CDMO Product Offered
11.7.3 Aptar Pharma Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aptar Pharma Main Business Overview
11.7.5 Aptar Pharma Latest Developments
11.8 Kindeva
11.8.1 Kindeva Company Information
11.8.2 Kindeva Inhalation CDMO Product Offered
11.8.3 Kindeva Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kindeva Main Business Overview
11.8.5 Kindeva Latest Developments
11.9 Sanner
11.9.1 Sanner Company Information
11.9.2 Sanner Inhalation CDMO Product Offered
11.9.3 Sanner Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanner Main Business Overview
11.9.5 Sanner Latest Developments
11.10 Particle Sciences
11.10.1 Particle Sciences Company Information
11.10.2 Particle Sciences Inhalation CDMO Product Offered
11.10.3 Particle Sciences Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Particle Sciences Main Business Overview
11.10.5 Particle Sciences Latest Developments
11.11 Experic
11.11.1 Experic Company Information
11.11.2 Experic Inhalation CDMO Product Offered
11.11.3 Experic Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Experic Main Business Overview
11.11.5 Experic Latest Developments
11.12 Enteris Biopharma
11.12.1 Enteris Biopharma Company Information
11.12.2 Enteris Biopharma Inhalation CDMO Product Offered
11.12.3 Enteris Biopharma Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Enteris Biopharma Main Business Overview
11.12.5 Enteris Biopharma Latest Developments
11.13 Catalent
11.13.1 Catalent Company Information
11.13.2 Catalent Inhalation CDMO Product Offered
11.13.3 Catalent Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Catalent Main Business Overview
11.13.5 Catalent Latest Developments
11.14 HCmed
11.14.1 HCmed Company Information
11.14.2 HCmed Inhalation CDMO Product Offered
11.14.3 HCmed Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 HCmed Main Business Overview
11.14.5 HCmed Latest Developments
11.15 Ritedose
11.15.1 Ritedose Company Information
11.15.2 Ritedose Inhalation CDMO Product Offered
11.15.3 Ritedose Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Ritedose Main Business Overview
11.15.5 Ritedose Latest Developments
11.16 Bespak
11.16.1 Bespak Company Information
11.16.2 Bespak Inhalation CDMO Product Offered
11.16.3 Bespak Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Bespak Main Business Overview
11.16.5 Bespak Latest Developments
11.17 Proveris
11.17.1 Proveris Company Information
11.17.2 Proveris Inhalation CDMO Product Offered
11.17.3 Proveris Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Proveris Main Business Overview
11.17.5 Proveris Latest Developments
11.18 Bend Bioscience
11.18.1 Bend Bioscience Company Information
11.18.2 Bend Bioscience Inhalation CDMO Product Offered
11.18.3 Bend Bioscience Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Bend Bioscience Main Business Overview
11.18.5 Bend Bioscience Latest Developments
11.19 Renejix
11.19.1 Renejix Company Information
11.19.2 Renejix Inhalation CDMO Product Offered
11.19.3 Renejix Inhalation CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Renejix Main Business Overview
11.19.5 Renejix Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1. Inhalation CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Inhalation CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Metered Dose Inhalers (MDIs)
Table 4. Major Players of Dry Powder Inhalers (DPIs)
Table 5. Major Players of Soft Mist Inhalers (SMIs)
Table 6. Major Players of Others
Table 7. Inhalation CDMO Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 9. Global Inhalation CDMO Market Size Market Share byType (2019-2024)
Table 10. Inhalation CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Inhalation CDMO Market Size Market Share by Application (2019-2024)
Table 13. Global Inhalation CDMO Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Inhalation CDMO Revenue Market Share by Player (2019-2024)
Table 15. Inhalation CDMO Key Players Head office and Products Offered
Table 16. Inhalation CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Inhalation CDMO Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Inhalation CDMO Market Size Market Share by Region (2019-2024)
Table 21. Global Inhalation CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Inhalation CDMO Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Inhalation CDMO Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Inhalation CDMO Market Size Market Share by Country (2019-2024)
Table 25. Americas Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 26. Americas Inhalation CDMO Market Size Market Share byType (2019-2024)
Table 27. Americas Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Inhalation CDMO Market Size Market Share by Application (2019-2024)
Table 29. APAC Inhalation CDMO Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Inhalation CDMO Market Size Market Share by Region (2019-2024)
Table 31. APAC Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 32. APAC Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Inhalation CDMO Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Inhalation CDMO Market Size Market Share by Country (2019-2024)
Table 35. Europe Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 36. Europe Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Inhalation CDMO Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Inhalation CDMO Market Size byType (2019-2024) & ($ millions)
Table 39. Middle East & Africa Inhalation CDMO Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Inhalation CDMO
Table 41. Key Market Challenges & Risks of Inhalation CDMO
Table 42. Key IndustryTrends of Inhalation CDMO
Table 43. Global Inhalation CDMO Market SizeForecast by Region (2025-2030) & ($ millions)
Table 44. Global Inhalation CDMO Market Size Market ShareForecast by Region (2025-2030)
Table 45. Global Inhalation CDMO Market SizeForecast byType (2025-2030) & ($ millions)
Table 46. Global Inhalation CDMO Market SizeForecast by Application (2025-2030) & ($ millions)
Table 47. Lonza Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 48. Lonza Inhalation CDMO Product Offered
Table 49. Lonza Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Vectura Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 53. Vectura Inhalation CDMO Product Offered
Table 54. Vectura Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Vectura Main Business
Table 56. Vectura Latest Developments
Table 57. Iconovo Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 58. Iconovo Inhalation CDMO Product Offered
Table 59. Iconovo Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Iconovo Main Business
Table 61. Iconovo Latest Developments
Table 62. CritiTech Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 63. CritiTech Inhalation CDMO Product Offered
Table 64. CritiTech Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. CritiTech Main Business
Table 66. CritiTech Latest Developments
Table 67. Hovione Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 68. Hovione Inhalation CDMO Product Offered
Table 69. Hovione Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Hovione Main Business
Table 71. Hovione Latest Developments
Table 72. Recipharm Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 73. Recipharm Inhalation CDMO Product Offered
Table 74. Recipharm Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Recipharm Main Business
Table 76. Recipharm Latest Developments
Table 77. Aptar Pharma Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 78. Aptar Pharma Inhalation CDMO Product Offered
Table 79. Aptar Pharma Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Aptar Pharma Main Business
Table 81. Aptar Pharma Latest Developments
Table 82. Kindeva Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 83. Kindeva Inhalation CDMO Product Offered
Table 84. Kindeva Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Kindeva Main Business
Table 86. Kindeva Latest Developments
Table 87. Sanner Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 88. Sanner Inhalation CDMO Product Offered
Table 89. Sanner Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Sanner Main Business
Table 91. Sanner Latest Developments
Table 92. Particle Sciences Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 93. Particle Sciences Inhalation CDMO Product Offered
Table 94. Particle Sciences Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Particle Sciences Main Business
Table 96. Particle Sciences Latest Developments
Table 97. Experic Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 98. Experic Inhalation CDMO Product Offered
Table 99. Experic Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Experic Main Business
Table 101. Experic Latest Developments
Table 102. Enteris Biopharma Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 103. Enteris Biopharma Inhalation CDMO Product Offered
Table 104. Enteris Biopharma Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Enteris Biopharma Main Business
Table 106. Enteris Biopharma Latest Developments
Table 107. Catalent Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 108. Catalent Inhalation CDMO Product Offered
Table 109. Catalent Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Catalent Main Business
Table 111. Catalent Latest Developments
Table 112. HCmed Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 113. HCmed Inhalation CDMO Product Offered
Table 114. HCmed Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. HCmed Main Business
Table 116. HCmed Latest Developments
Table 117. Ritedose Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 118. Ritedose Inhalation CDMO Product Offered
Table 119. Ritedose Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Ritedose Main Business
Table 121. Ritedose Latest Developments
Table 122. Bespak Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 123. Bespak Inhalation CDMO Product Offered
Table 124. Bespak Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Bespak Main Business
Table 126. Bespak Latest Developments
Table 127. Proveris Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 128. Proveris Inhalation CDMO Product Offered
Table 129. Proveris Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Proveris Main Business
Table 131. Proveris Latest Developments
Table 132. Bend Bioscience Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 133. Bend Bioscience Inhalation CDMO Product Offered
Table 134. Bend Bioscience Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. Bend Bioscience Main Business
Table 136. Bend Bioscience Latest Developments
Table 137. Renejix Details, CompanyType, Inhalation CDMO Area Served and Its Competitors
Table 138. Renejix Inhalation CDMO Product Offered
Table 139. Renejix Inhalation CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. Renejix Main Business
Table 141. Renejix Latest Developments
LIST OFFIGURES
.
Figure 1. Inhalation CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Inhalation CDMO Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Inhalation CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Inhalation CDMO Sales Market Share by Country/Region (2023)
Figure 8. Inhalation CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Inhalation CDMO Market Size Market Share byType in 2023
Figure 10. Inhalation CDMO in Commercial
Figure 11. Global Inhalation CDMO Market: Commercial (2019-2024) & ($ millions)
Figure 12. Inhalation CDMO in Academic Research
Figure 13. Global Inhalation CDMO Market: Academic Research (2019-2024) & ($ millions)
Figure 14. Inhalation CDMO in Others
Figure 15. Global Inhalation CDMO Market: Others (2019-2024) & ($ millions)
Figure 16. Global Inhalation CDMO Market Size Market Share by Application in 2023
Figure 17. Global Inhalation CDMO Revenue Market Share by Player in 2023
Figure 18. Global Inhalation CDMO Market Size Market Share by Region (2019-2024)
Figure 19. Americas Inhalation CDMO Market Size 2019-2024 ($ millions)
Figure 20. APAC Inhalation CDMO Market Size 2019-2024 ($ millions)
Figure 21. Europe Inhalation CDMO Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Inhalation CDMO Market Size 2019-2024 ($ millions)
Figure 23. Americas Inhalation CDMO Value Market Share by Country in 2023
Figure 24. United States Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Inhalation CDMO Market Size Market Share by Region in 2023
Figure 29. APAC Inhalation CDMO Market Size Market Share byType (2019-2024)
Figure 30. APAC Inhalation CDMO Market Size Market Share by Application (2019-2024)
Figure 31. China Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 35. India Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Inhalation CDMO Market Size Market Share by Country in 2023
Figure 38. Europe Inhalation CDMO Market Size Market Share byType (2019-2024)
Figure 39. Europe Inhalation CDMO Market Size Market Share by Application (2019-2024)
Figure 40. Germany Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 41.France Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Inhalation CDMO Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Inhalation CDMO Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa Inhalation CDMO Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 51.Turkey Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Inhalation CDMO Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 54. APAC Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 55. Europe Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 57. United States Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 58. Canada Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 59. Mexico Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 60. Brazil Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 61. China Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 62. Japan Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 63. Korea Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 65. India Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 66. Australia Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 67. Germany Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 68.France Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 69. UK Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 70. Italy Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 71. Russia Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 72. Egypt Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 73. South Africa Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 74. Israel Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 75.Turkey Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Inhalation CDMO Market Size 2025-2030 ($ millions)
Figure 77. Global Inhalation CDMO Market Size Market ShareForecast byType (2025-2030)
Figure 78. Global Inhalation CDMO Market Size Market ShareForecast by Application (2025-2030)
